Tag Archives: generics

“A sweetheart deal” “deplorable” “immoral and unacceptable” “Massive victory for big pharma” . . . We’re reading about TPP’s pharma rules, and an update on a 5000-percent price hike

By on .

(Spoiler alert: The price of a life-saving treatment for toxoplasmosis remains unchanged, a month after company CEO Martin Shkreli said it would drop . . . )  But first: The world got glimpse of what the Trans Pacific Partnership offers pharmaceutical companies last week with the WikiLeaks release of the treaty’s Intellectual Property Rights chapter, a […]

WHO’s PQP: How affordable antiretroviral and other treatments owe much to “little known part of WHO” reliant on two funders

By on .

In 1999, a small South Africa study revealed disturbing news about a medicine used in first line directly observed therapy for tuberculosis:  it contained the right amount of the most essential ingredient but testing showed it was not being absorbed into patients’ systems. If the small study was representative of what was happening on a […]

“The beauty of this place,” case studies, cost-effectiveness, and more . . .

By on .

“What I love about the Senate”: “I love that instead of fighting against each other, Bill Frist, the former Republican leader, and I were able to join forces to fight HIV and AIDS around the globe and to convince an unlikely conservative named Jesse Helms to support and pass a bill unanimously that has saved […]

100th Antiretroviral Drug approved by FDA for PEPFAR

By on .

Federal officials today celebrated the approval of the 100th antiretroviral drug authorized under an expedited regulatory framework created five years ago, as a way to fast-track the delivery of cheap HIV drugs to the developing world through the PEPFAR program. A panel discussion, held at the Pan American Health Organization Headquarters to mark the milestone, […]